An internal database and research methods were used to evaluate the impact of clopidogrel on cardiac surgical bleeding. This quality improvement initiative, led by the clinical nurse specialist, showed that preoperative exposure to clopidogrel was associated with significant increases in chest tube output, blood product use, and reoperation for bleeding rates that were 10-fold higher than for control patients (0.85% versus 8.3%, P = 0.027). Acute care costs averaged $2,680 more for patients who received clopidogrel (P = 0.1936). After implementation of an interdepartmental clinical practice guideline, preoperative exposure to clopidogrel dropped from 39% to 6.3% (P = 0.0000). This drop was accompanied by reductions in chest tube output, blood product use, and bleeding complications, with improved achievement of clinical benchmarks. The availability of internal evidence to support achievement of best practices was an essential factor in the implementation of this interdepartmental change. Comprehensive database systems and advanced practice nurses are highlighted as essential components of evidence-based programs.
Skip Nav Destination
Evidence-based Practice| November 01 2001
Quality Care Outcomes in Cardiac Surgery: The Role of Evidence-based Practice
S. Jill Ley, RN, MS, CCRN, CNS
From the Department of Quality and Clinical Resource Management, California Pacific Medical Center, and the Department of Physiological Nursing, University of California, San Francisco.
Reprint requests to S. Jill Ley, RN, MS, CCRN, CNS, 62 Paseo Way, Greenbrae, CA 94904 (e-mail: firstname.lastname@example.org).
Search for other works by this author on:
AACN Adv Crit Care (2001) 12 (4): 606–617.
- Views Icon Views
- Share Icon Share
S. Jill Ley; Quality Care Outcomes in Cardiac Surgery: The Role of Evidence-based Practice. AACN Adv Crit Care 1 November 2001; 12 (4): 606–617. doi:
Download citation file: